407 related articles for article (PubMed ID: 25193423)
1. Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study.
Cleeland CS; Mayer M; Dreyer NA; Yim YM; Yu E; Su Z; Mun Y; Sloan JA; Kaufman PA
Breast; 2014 Dec; 23(6):763-9. PubMed ID: 25193423
[TBL] [Abstract][Full Text] [Related]
2. The relationship between symptom severity and symptom interference, education, age, marital status, and type of chemotherapy treatment in Israeli women with early-stage breast cancer.
Prigozin A; Uziely B; Musgrave CF
Oncol Nurs Forum; 2010 Nov; 37(6):E411-8. PubMed ID: 21059574
[TBL] [Abstract][Full Text] [Related]
3. Symptoms of hormonal therapy and social support: Is there a connection? Comparison of symptom severity, symptom interference and social support among breast cancer patients receiving and not receiving adjuvant hormonal treatment.
Ochayon L; Tunin R; Yoselis A; Kadmon I
Eur J Oncol Nurs; 2015 Jun; 19(3):260-7. PubMed ID: 25529935
[TBL] [Abstract][Full Text] [Related]
4. Usual and worst symptom severity and interference with function in breast cancer survivors.
Berger AM; Visovsky C; Hertzog M; Holtz S; Loberiza FR
J Support Oncol; 2012; 10(3):112-8. PubMed ID: 22277573
[TBL] [Abstract][Full Text] [Related]
5. Pain, fatigue, disturbed sleep and distress comprised a symptom cluster that related to quality of life and functional status of lung cancer surgery patients.
Lin S; Chen Y; Yang L; Zhou J
J Clin Nurs; 2013 May; 22(9-10):1281-90. PubMed ID: 23574291
[TBL] [Abstract][Full Text] [Related]
6. Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks.
Gabrilove JL; Perez EA; Tomita DK; Rossi G; Cleeland CS
Cancer; 2007 Oct; 110(7):1629-40. PubMed ID: 17694552
[TBL] [Abstract][Full Text] [Related]
7. The association of chemotherapy versus hormonal therapy and health outcomes among patients with hormone receptor-positive, HER2-negative metastatic breast cancer: experience from the patient perspective.
Gupta S; Zhang J; Jerusalem G
Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):929-40. PubMed ID: 25130198
[TBL] [Abstract][Full Text] [Related]
8. Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients.
Cheung YT; Shwe M; Chui WK; Chay WY; Ang SF; Dent RA; Yap YS; Lo SK; Ng RC; Chan A
Ann Pharmacother; 2012 Dec; 46(12):1645-55. PubMed ID: 23249868
[TBL] [Abstract][Full Text] [Related]
9. Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy.
Payne JK; Held J; Thorpe J; Shaw H
Oncol Nurs Forum; 2008 Jul; 35(4):635-42. PubMed ID: 18591167
[TBL] [Abstract][Full Text] [Related]
10. Prospective longitudinal evaluation of a symptom cluster in breast cancer.
Sanford SD; Beaumont JL; Butt Z; Sweet JJ; Cella D; Wagner LI
J Pain Symptom Manage; 2014 Apr; 47(4):721-30. PubMed ID: 23880589
[TBL] [Abstract][Full Text] [Related]
11. Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials.
George GC; Iwuanyanwu EC; Anderson KO; Yusuf A; Zinner RG; Piha-Paul SA; Tsimberidou AM; Naing A; Fu S; Janku F; Subbiah V; Cleeland CS; Mendoza TR; Hong DS
Cancer; 2016 Nov; 122(21):3401-3409. PubMed ID: 27412379
[TBL] [Abstract][Full Text] [Related]
12. Impact of age, sex, physical function, health-related quality of life, and treatment with adalimumab on work status and work productivity of patients with ankylosing spondylitis.
Maksymowych WP; Gooch KL; Wong RL; Kupper H; van der Heijde D
J Rheumatol; 2010 Feb; 37(2):385-92. PubMed ID: 19955052
[TBL] [Abstract][Full Text] [Related]
13. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module.
Armstrong TS; Gning I; Mendoza TR; Vera-Bolanos E; Gilbert MR; Rhines LD; Weinberg JS; Sanchez-Williams G; Levin V; Burton AW; Cleeland C
J Neurosurg Spine; 2010 Apr; 12(4):421-30. PubMed ID: 20367379
[TBL] [Abstract][Full Text] [Related]
14. The effect of EEG biofeedback on reducing postcancer cognitive impairment.
Alvarez J; Meyer FL; Granoff DL; Lundy A
Integr Cancer Ther; 2013 Nov; 12(6):475-87. PubMed ID: 23584550
[TBL] [Abstract][Full Text] [Related]
15. Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD)--results from a cross-sectional study.
Wahlqvist P; Carlsson J; Stålhammar NO; Wiklund I
Value Health; 2002; 5(2):106-13. PubMed ID: 11918826
[TBL] [Abstract][Full Text] [Related]
16. Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients.
Wang XS; Wang Y; Guo H; Mendoza TR; Hao XS; Cleeland CS
Cancer; 2004 Oct; 101(8):1890-901. PubMed ID: 15386315
[TBL] [Abstract][Full Text] [Related]
17. Symptom burden of cancer patients: validation of the German M. D. Anderson Symptom Inventory: a cross-sectional multicenter study.
Schmidt H; Cleeland CS; Bauer A; Landenberger M; Jahn P
J Pain Symptom Manage; 2015 Jan; 49(1):117-25. PubMed ID: 24858739
[TBL] [Abstract][Full Text] [Related]
18. Cancer-related symptom assessment in France: validation of the French M. D. Anderson Symptom Inventory.
Guirimand F; Buyck JF; Lauwers-Allot E; Revnik J; Kerguen T; Aegerter P; Brasseur L; Cleeland CS
J Pain Symptom Manage; 2010 Apr; 39(4):721-33. PubMed ID: 20413059
[TBL] [Abstract][Full Text] [Related]
19. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module.
Rosenthal DI; Mendoza TR; Chambers MS; Asper JA; Gning I; Kies MS; Weber RS; Lewin JS; Garden AS; Ang KK; S Wang X; Cleeland CS
Head Neck; 2007 Oct; 29(10):923-31. PubMed ID: 17358040
[TBL] [Abstract][Full Text] [Related]
20. The symptom burden of patients with hematological malignancy: a cross-sectional observational study.
Manitta V; Zordan R; Cole-Sinclair M; Nandurkar H; Philip J
J Pain Symptom Manage; 2011 Sep; 42(3):432-42. PubMed ID: 21477979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
